Large-scale testing (Phase 3)Study completedNCT05352815
What this trial is testing
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,291